Evidence map›Paper›PMID 33623619›Full record

ArticleThe Pan African medical journal2020

Ethical issues in the COVID-19 pandemic control preparedness in a developing economy.

Ayodele Jegede, IkeOluwapo Ajayi, Simisola Akintola, Catherine Falade, Isaac Oluwafemi Dipeolu, Simeon Cadmus, Ajala Aderemi, Abayomi Olaifa, Olufemi Olatoye, Odunayo Akinyemi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayodele JegedeDepartment of Sociology, Faculty of the Social Sciences, University of Ibadan, Ibadan, Nigeria.
IkeOluwapo AjayiEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Simisola AkintolaEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Catherine FaladeDepartment of Pharmacology and Therapeutics, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Isaac Oluwafemi DipeoluEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Simeon CadmusEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Ajala AderemiEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Abayomi OlaifaEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Olufemi OlatoyeEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.
Odunayo AkinyemiEthics Sub-committee of the Coronavirus Pandemic Response Committee, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adequate preparation for highly pathogenic infectious disease pandemic can reduce the incidence, prevalence and burden of diseases like COVID-19 pandemic. An antidote to the spread of the disease is adequate preparation for its control since there is no proven curative measure yet. Effective management of identified cases, social distancing, contact tracing and provision of basic infrastructure to facilitate compliance with preventive measures, testing are proven management strategies. Although these measures seem to be the best options presently, it is important to pay attention to ethical issues arising from the implementation process to ensure best practice. While disease epidemic is not alien to human societies, lessons from previous outbreaks are vital for addressing future outbreaks. For effective control of this pandemic, there should be a clear definition of social distancing in terms of distance and space in line with the WHO definition, adequate provision of basic amenities, screening and testing with specific criteria for selecting those to be screened. Also, there should be a free testing procedure, access to treatment opportunities for those who test positive, ethical free contact tracing practice, respect for the autonomy of those to be tested, and global best practice of open science, open data and data sharing practices. In conclusion, a framework/guideline for epidemic/pandemic ethics guidance should be developed while an ethical sensitive communication manual should be prepared for public engagement on epidemic and pandemic.

Indexed as

COVID-19 TestingContact TracingCOVID-19Developing CountriesDisease OutbreaksHealth Services AccessibilityHumansMass ScreeningPhysical Distancingdisease controlethicsPandemic preparedness

Identifiers

PMID33623619
PMCPMC7875799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.